{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T12:33:02Z","timestamp":1793363582170,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U54DK137314"],"award-info":[{"award-number":["U54DK137314"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["AR041215"],"award-info":[{"award-number":["AR041215"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["K24AR076975"],"award-info":[{"award-number":["K24AR076975"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016526","name":"George M. O'Brien Michigan Kidney Translational Core Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016526","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018208","name":"Cure JM Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018208","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017759","name":"Childhood Arthritis and Rheumatology Research Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017759","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000980","name":"Arthritis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000980","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014989","name":"The Chan Zuckerberg Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014989","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ard.2025.07.020","type":"journal-article","created":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T19:10:17Z","timestamp":1757185817000},"page":"1836-1851","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Discovery of tissue-specific proteomic signatures in juvenile dermatomyositis highlights pathways reflecting persistent disease activity, clinical heterogeneity, and myositis-specific autoantibody subtype"],"prefix":"10.1016","volume":"84","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0420-7933","authenticated-orcid":false,"given":"Jessica","family":"Neely","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara E.","family":"Sabbagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Dvergsten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chioma","family":"Madubata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celine C.","family":"Berthier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zilan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Goudsmit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Matossian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean P.","family":"Ferris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela K.","family":"Fragiadakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Sirota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Michelle","family":"Kahlenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica L.","family":"Turnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ard.2025.07.020_bib0001","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3109\/03009742.2011.608376","article-title":"Long-term outcome in patients with juvenile dermatomyositis: a cross-sectional follow-up study","volume":"41","author":"Mathiesen","year":"2012","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.ard.2025.07.020_bib0002","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.3389\/fimmu.2018.02951","article-title":"Systemic and tissue inflammation in juvenile dermatomyositis: from pathogenesis to the quest for monitoring tools","volume":"9","author":"Wienke","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.ard.2025.07.020_bib0003","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jpeds.2005.10.032","article-title":"Duration of illness is an important variable for untreated children with juvenile dermatomyositis","volume":"148","author":"Pachman","year":"2006","journal-title":"J Pediatr"},{"key":"10.1016\/j.ard.2025.07.020_bib0004","doi-asserted-by":"crossref","first-page":"552","DOI":"10.3390\/biomedicines11020552","article-title":"The von Willebrand factor antigen reflects the juvenile dermatomyositis disease activity score","volume":"11","author":"Gibbs","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.ard.2025.07.020_bib0005","first-page":"739","article-title":"Monitoring disease activity in juvenile dermatomyositis: the role of von Willebrand factor and muscle enzymes","volume":"21","author":"Guzm\u00e1n","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ard.2025.07.020_bib0006","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/diagnostics12010008","article-title":"Clues to disease activity in juvenile dermatomyositis: neopterin and other biomarkers","volume":"12","author":"Khojah","year":"2021","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.ard.2025.07.020_bib0007","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/cei.13404","article-title":"A high level of serum neopterin is associated with rapidly progressive interstitial lung disease and reduced survival in dermatomyositis","volume":"199","author":"Peng","year":"2020","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.ard.2025.07.020_bib0008","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2119\/2006-00085.Baechler","article-title":"An interferon signature in the peripheral blood of dermatomyositis patients is associated with disease activity","volume":"13","author":"Baechler","year":"2007","journal-title":"Mol Med"},{"key":"10.1016\/j.ard.2025.07.020_bib0009","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.902232","article-title":"Multi-modal single-cell sequencing identifies cellular immunophenotypes associated with juvenile dermatomyositis disease activity","volume":"13","author":"Neely","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.ard.2025.07.020_bib0010","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13075-020-02160-9","article-title":"Expression of interferon-regulated genes in juvenile dermatomyositis versus Mendelian autoinflammatory interferonopathies","volume":"22","author":"Kim","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.ard.2025.07.020_bib0011","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1002\/art.40800","article-title":"Muscle expression of type I and type II interferons is increased in juvenile dermatomyositis and related to clinical and histologic features","volume":"71","author":"Moneta","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.ard.2025.07.020_bib0012","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1002\/art.41615","article-title":"Comparison of lesional juvenile myositis and lupus skin reveals overlapping yet unique disease pathophysiology","volume":"73","author":"Turnier","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.ard.2025.07.020_bib0013","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/acr2.11618","article-title":"Type 1 interferon-stimulated gene expression and disease activity in pediatric rheumatic diseases: no composite scores needed?","volume":"5","author":"Weiden","year":"2023","journal-title":"ACR Open Rheumatol"},{"key":"10.1016\/j.ard.2025.07.020_bib0014","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/s41598-021-04302-8","article-title":"Transcriptomes of peripheral blood mononuclear cells from juvenile dermatomyositis patients show elevated inflammation even when clinically inactive","volume":"12","author":"Roberson","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.ard.2025.07.020_bib0015","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1080\/14656566.2024.2392021","article-title":"Current evidence for janus kinase inhibitors in adult and juvenile dermatomyositis and key comparisons","volume":"25","author":"Wallwork","year":"2024","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.ard.2025.07.020_bib0016","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1038\/s41591-024-03092-6","article-title":"A unified metric of human immune health","volume":"30","author":"Sparks","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.ard.2025.07.020_bib0017","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s41927-020-00150-7","article-title":"Serum protein biomarkers for juvenile dermatomyositis: a pilot study","volume":"4","author":"Tawalbeh","year":"2020","journal-title":"BMC Rheumatol"},{"key":"10.1016\/j.ard.2025.07.020_bib0018","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1093\/rheumatology\/kead165","article-title":"In-depth proteomic analysis of juvenile dermatomyositis serum reveals protein expression associated with muscle-specific autoantibodies","volume":"62","author":"Sato","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ard.2025.07.020_bib0019","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s13075-024-03421-7","article-title":"Neutrophil and mononuclear leukocyte pathways and upstream regulators revealed by serum proteomics of adult and juvenile dermatomyositis","volume":"26","author":"Sparling","year":"2024","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.ard.2025.07.020_bib0020","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.3899\/jrheum.181275","article-title":"Endothelial activation markers as disease activity and damage measures in juvenile dermatomyositis","volume":"47","author":"Kishi","year":"2020","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ard.2025.07.020_bib0021","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1002\/art.41236","article-title":"Endothelial and inflammation biomarker profiles at diagnosis reflecting clinical heterogeneity and serving as a prognostic tool for treatment response in two independent cohorts of patients with juvenile dermatomyositis","volume":"72","author":"Wienke","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.ard.2025.07.020_bib0022","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1093\/rheumatology\/keaa270","article-title":"Biomarker profiles of endothelial activation and dysfunction in rare systemic autoimmune diseases: implications for cardiovascular risk","volume":"60","author":"Wienke","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ard.2025.07.020_bib0023","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1002\/art.42615","article-title":"Shared and distinctive transcriptomic and proteomic pathways in adult and juvenile dermatomyositis","volume":"75","author":"Ward","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.ard.2025.07.020_bib0024","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1136\/annrheumdis-2017-212141","article-title":"Development of a consensus core dataset in juvenile dermatomyositis for clinical use to inform research","volume":"77","author":"McCann","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ard.2025.07.020_bib0025","doi-asserted-by":"crossref","first-page":"4281","DOI":"10.1021\/acs.jproteome.7b00375","article-title":"Progress on the HUPO draft human proteome: 2017 metrics of the human proteome project","volume":"16","author":"Omenn","year":"2017","journal-title":"J Proteome Res"},{"key":"10.1016\/j.ard.2025.07.020_bib0026","article-title":"DoubletFinder: doublet detection in single-cell RNA sequencing data using artificial nearest neighbors","volume":"8","author":"McGinnis","year":"2019","journal-title":"Cell Syst"},{"key":"10.1016\/j.ard.2025.07.020_bib0027","doi-asserted-by":"crossref","first-page":"giaa151","DOI":"10.1093\/gigascience\/giaa151","article-title":"SoupX removes ambient RNA contamination from droplet-based single-cell RNA sequencing data","volume":"9","author":"Young","year":"2020","journal-title":"Gigascience"},{"key":"10.1016\/j.ard.2025.07.020_bib0028","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","article-title":"Fast, sensitive and accurate integration of single-cell data with Harmony","volume":"16","author":"Korsunsky","year":"2019","journal-title":"Nat Methods"},{"key":"10.1016\/j.ard.2025.07.020_bib0029","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/rheumatology\/kel099","article-title":"The Juvenile Dermatomyositis National Registry and Repository (UK and Ireland)\u2013clinical characteristics of children recruited within the first 5 yr","volume":"45","author":"McCann","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ard.2025.07.020_bib0030","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/MD.0b013e31827f264d","article-title":"The clinical phenotypes of the juvenile idiopathic inflammatory myopathies","volume":"92","author":"Shah","year":"2013","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ard.2025.07.020_bib0031","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1126\/science.1059108","article-title":"Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death","volume":"292","author":"Wei","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.ard.2025.07.020_bib0032","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/MD.0b013e31829d08f9","article-title":"The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies","volume":"92","author":"Rider","year":"2013","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ard.2025.07.020_bib0033","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1161\/CIRCULATIONAHA.107.689984","article-title":"Laminin-alpha4 and integrin-linked kinase mutations cause human cardiomyopathy via simultaneous defects in cardiomyocytes and endothelial cells","volume":"116","author":"Kn\u00f6ll","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ard.2025.07.020_bib0034","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.atherosclerosis.2023.03.010","article-title":"Interleukin-6 trans-signaling induced laminin switch contributes to reduced trans-endothelial migration of granulocytic cells","volume":"371","author":"Zegeye","year":"2023","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ard.2025.07.020_bib0035","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.immuni.2019.03.025","article-title":"Shared and distinct functions of type I and type III interferons","volume":"50","author":"Lazear","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.ard.2025.07.020_bib0038","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104048","article-title":"Upregulation of immunoproteasome subunits in myositis indicates active inflammation with involvement of antigen presenting cells, CD8 T-cells and IFN\u0393","volume":"9","author":"Ghannam","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ard.2025.07.020_bib0039","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1136\/ard-2022-223469","article-title":"Role of CD14+ monocyte-derived oxidised mitochondrial DNA in the inflammatory interferon type 1 signature in juvenile dermatomyositis","volume":"82","author":"Wilkinson","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ard.2025.07.020_bib0036","doi-asserted-by":"crossref","first-page":"e8611","DOI":"10.7717\/peerj.8611","article-title":"Co-expression network analysis reveals the pivotal role of mitochondrial dysfunction and interferon signature in juvenile dermatomyositis","volume":"8","author":"Zhong","year":"2020","journal-title":"PeerJ"},{"key":"10.1016\/j.ard.2025.07.020_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2023.103061","article-title":"Role of mitochondria in the myopathy of juvenile dermatomyositis and implications for skeletal muscle calcinosis","volume":"138","author":"Duvvuri","year":"2023","journal-title":"J Autoimmun"},{"key":"10.1016\/j.ard.2025.07.020_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.cytox.2022.100063","article-title":"An exploratory study of circulating cytokines and chemokines in patients with muscle disorders proposes CD40L and CCL5 represent general disease markers while CXCL10 differentiates between patients with an autoimmune myositis","volume":"4","author":"De Paepe","year":"2022","journal-title":"Cytokine X"},{"key":"10.1016\/j.ard.2025.07.020_bib0041","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3389\/fphar.2020.00146","article-title":"Chemokine receptor 5, a double-edged sword in metabolic syndrome and cardiovascular disease","volume":"11","author":"Zhang","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ard.2025.07.020_bib0042","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.freeradbiomed.2013.01.025","article-title":"Mitochondria-targeted drugs enhance Nlrp3 inflammasome-dependent IL-1beta secretion in association with alterations in cellular redox and energy status","volume":"60","author":"Jabaut","year":"2013","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.ard.2025.07.020_bib0043","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13395-015-0048-4","article-title":"Upregulated IL-1beta in dysferlin-deficient muscle attenuates regeneration by blunting the response to pro-inflammatory macrophages","volume":"5","author":"Cohen","year":"2015","journal-title":"Skelet Muscle"},{"key":"10.1016\/j.ard.2025.07.020_bib0044","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.tibs.2016.04.004","article-title":"SOD2 and the mitochondrial UPR: partners regulating cellular phenotypic transitions","volume":"41","author":"He","year":"2016","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.ard.2025.07.020_bib0045","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1093\/rheumatology\/keac429","article-title":"Evaluating the value of superoxide dismutase in anti-MDA5-positive dermatomyositis associated with interstitial lung disease","volume":"62","author":"Huang","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ard.2025.07.020_bib0046","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.3390\/ijms19051306","article-title":"Positive and negative regulation of angiogenesis by soluble vascular endothelial growth factor receptor-1","volume":"19","author":"Failla","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ard.2025.07.020_bib0047","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/embor.2011.194","article-title":"Endothelial basement membrane limits tip cell formation by inducing Dll4\/Notch signalling in vivo","volume":"12","author":"Stenzel","year":"2011","journal-title":"EMBO Rep"},{"key":"10.1016\/j.ard.2025.07.020_bib0048","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1002\/art.41625","article-title":"From diagnosis to prognosis: revisiting the meaning of muscle ISG15 overexpression in juvenile inflammatory myopathies","volume":"73","author":"Hou","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.ard.2025.07.020_bib0049","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1164\/ajrccm.165.3.2107134","article-title":"Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases","volume":"165","author":"Ohnishi","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ard.2025.07.020_bib0050","first-page":"1068","article-title":"Surfactant protein D is associated with 3-month mortality of anti-MDA5 antibody-interstitial lung disease","volume":"38","author":"Lyu","year":"2020","journal-title":"Clin Exp Rheumatol"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496725042918?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496725042918?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T04:16:41Z","timestamp":1779855401000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496725042918"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":50,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0003496725042918"],"URL":"https:\/\/doi.org\/10.1016\/j.ard.2025.07.020","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of tissue-specific proteomic signatures in juvenile dermatomyositis highlights pathways reflecting persistent disease activity, clinical heterogeneity, and myositis-specific autoantibody subtype","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ard.2025.07.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology (EULAR).","name":"copyright","label":"Copyright"}]}}